0001104659-25-103638.txt : 20251029 0001104659-25-103638.hdr.sgml : 20251029 20251029121114 ACCESSION NUMBER: 0001104659-25-103638 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251029 DATE AS OF CHANGE: 20251029 EFFECTIVENESS DATE: 20251029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chirality Biosciences, Inc. CENTRAL INDEX KEY: 0002094367 ORGANIZATION NAME: EIN: 992561083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562393 FILM NUMBER: 251428629 BUSINESS ADDRESS: STREET 1: 3 BIOSCIENCE PARK DRIVE, ROOM 508 CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: (516) 672-8623 MAIL ADDRESS: STREET 1: 3 BIOSCIENCE PARK DRIVE, ROOM 508 CITY: FARMINGDALE STATE: NY ZIP: 11735 D 1 primary_doc.xml X0708 D LIVE 0002094367 Chirality Biosciences, Inc. 3 BIOSCIENCE PARK DRIVE, ROOM 508 FARMINGDALE NY NEW YORK 11735 (516) 672-8623 DELAWARE CMS Biotechnologies, Inc. None Corporation true 2023 Arielle Gabalski c/o Chirality Biosciences 3 Bioscience Park Drive, Room 508 Farmingdale NY NEW YORK 11735 Executive Officer Director Robert Kayton c/o Chirality Biosciences 3 Bioscience Park Drive, Room 508 Farmingdale NY NEW YORK 11735 Director Joanna Jennings Eagle c/o Chirality Biosciences 3 Bioscience Park Drive, Room 508 Farmingdale NY NEW YORK 11735 Executive Officer Other Decline to Disclose 06b false 2025-10-17 false true false 0 4100000 3105000 995000 Total Offering Amount & Total Amount Sold includes $1,100,000 of Convertible Securities converted on a non-cash basis to Series Pre-Seed 2 Shares. false 9 0 0 0 false Chirality Biosciences, Inc. /s/ Arielle Gabalski Arielle Gabalski President & Chief Executive Officer 2025-10-27